These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2310015)

  • 21. Colorimetric determination of beta-cyclodextrin: two assay modifications based on molecular complexation of phenolphtalein.
    Mäkelä M; Korpela T; Laakso S
    J Biochem Biophys Methods; 1987 Apr; 14(2):85-92. PubMed ID: 3693795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inclusion complexes of cinnarizine with beta-cyclodextrin in aqueous solution and in the solid state.
    Tokumura T; Ueda H; Tsushima Y; Kasai M; Kayano M; Amada I; Nagai T
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4179-84. PubMed ID: 6529813
    [No Abstract]   [Full Text] [Related]  

  • 23. Formation of a complex between the analgesic, 6-benzoyl-benzoxazolidinone (CERM 10194), and beta-cyclodextrin.
    Si-Nang L; Simond J; Schiff V; Trottier D; Pourrat A
    Pharm Acta Helv; 1985; 60(4):112-6. PubMed ID: 4011622
    [No Abstract]   [Full Text] [Related]  

  • 24. [A structural study of the inclusion compound of piroxicam with beta-cyclodextrin by NMR].
    Miao ZC; Du ZH; Xu GF; Shi TS
    Yao Xue Xue Bao; 1988; 23(9):682-7. PubMed ID: 3256202
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of chemically-bonded cyclodextrin stationary phase for high performance liquid chromatographic determination of feldene capsules.
    Ahmed AN; el-Gizawy SM
    J Chromatogr Sci; 1987 Sep; 25(9):424-6. PubMed ID: 3667839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complexation of several drugs with water-soluble cyclodextrin polymer.
    Szeman J; Ueda H; Szejtli J; Fenyvesi E; Machida Y; Nagai T
    Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):282-8. PubMed ID: 3594657
    [No Abstract]   [Full Text] [Related]  

  • 27. Suppositories containing beta-cyclodextrin complexes. Part 1: Stability studies.
    Szente L; Apostol I; Szejtli J
    Pharmazie; 1984 Oct; 39(10):697-9. PubMed ID: 6522449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The effect of water structure on cyclodextrin inclusion and light sensitivity of epinephrine].
    Hüttenrauch R; Fricke S; Knop M
    Pharmazie; 1985 Mar; 40(3):199-200. PubMed ID: 4023038
    [No Abstract]   [Full Text] [Related]  

  • 29. Planar chromatographic separation of enantiomers and diastereomers with cyclodextrin mobile phase additives.
    Armstrong DW; He FY; Han SM
    J Chromatogr; 1988 Sep; 448(3):345-54. PubMed ID: 3243840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of cyclodextrins on sparingly soluble salts.
    Hirsch W; Fried V; Altman L
    J Pharm Sci; 1985 Oct; 74(10):1123-5. PubMed ID: 4078713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of the beta-cyclodextrin-hydrocortisone inclusion compound.
    Frank SG; Kavaliunas DR
    J Pharm Sci; 1983 Oct; 72(10):1215-7. PubMed ID: 6644576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of cyclodextrins in biological fluids by high-performance liquid chromatography with negative colorimetric detection using post-column complexation with phenolphthalein.
    Frijlink HW; Visser J; Drenth BF
    J Chromatogr; 1987 Apr; 415(2):325-33. PubMed ID: 3584371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative structure-stability relationships among inclusion complexes of cyclodextrins. I: Barbituric acid derivatives.
    Lopata A; Darvas F; Stadler-Szóke A; Szejtli J
    J Pharm Sci; 1985 Feb; 74(2):211-3. PubMed ID: 3989695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of freezing point depression to drug interaction studies. I. Interaction between cyclodextrins and alcohols.
    Suzuki M; Ueda S; Kusai A
    Chem Pharm Bull (Tokyo); 1988 Feb; 36(2):720-5. PubMed ID: 3409380
    [No Abstract]   [Full Text] [Related]  

  • 35. Dissolution behavior of prednisolone from solid dispersion systems with cyclodextrins and polyvinylpyrrolidone.
    Fukuda N; Higuchi N; Ohno M; Kenmochi H; Sekikawa H; Takada M
    Chem Pharm Bull (Tokyo); 1986 Mar; 34(3):1366-9. PubMed ID: 3731351
    [No Abstract]   [Full Text] [Related]  

  • 36. Improved competitive indicator methods for the study of alpha-cyclodextrin complexes.
    Pendergast DD; Connors KA
    J Pharm Sci; 1984 Dec; 73(12):1779-83. PubMed ID: 6527255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improving the aqueous stability of prostaglandin E2 and prostaglandin A2 by inclusion complexation with methylated-beta-cyclodextrins.
    Hirayama F; Kurihara M; Uekama K
    Chem Pharm Bull (Tokyo); 1984 Oct; 32(10):4237-40. PubMed ID: 6597735
    [No Abstract]   [Full Text] [Related]  

  • 38. Inclusion complexation of prostaglandin F2 alpha with gamma-cyclodextrin in solution and solid phases.
    Uekama K; Hirayama F; Fujise A; Otagiri M; Inaba K; Saitô H
    J Pharm Sci; 1984 Mar; 73(3):382-4. PubMed ID: 6585547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heptakis(2,6-di-O-methyl)-beta-cyclodextrin complexation with the antitumor agent chlorambucil.
    Green AR; Guillory JK
    J Pharm Sci; 1989 May; 78(5):427-31. PubMed ID: 2746481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spectral displacement techniques for studying the binding of spectroscopically transparent ligands to cyclodextrins.
    Selvidge LA; Eftink MR
    Anal Biochem; 1986 May; 154(2):400-8. PubMed ID: 3755301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.